company background image
5GH logo

Guardant Health DB:5GH Stock Report

Last Price

€15.80

Market Cap

€1.9b

7D

-2.5%

1Y

-29.5%

Updated

25 Mar, 2024

Data

Company Financials +

5GH Stock Overview

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally.

5GH fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Guardant Health, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Guardant Health
Historical stock prices
Current Share PriceUS$15.80
52 Week HighUS$36.60
52 Week LowUS$15.80
Beta0.87
1 Month Change-11.24%
3 Month Change-35.77%
1 Year Change-29.48%
3 Year Change-86.14%
5 Year Changen/a
Change since IPO-83.28%

Recent News & Updates

Recent updates

Shareholder Returns

5GHDE HealthcareDE Market
7D-2.5%-1.8%1.6%
1Y-29.5%-2.3%6.4%

Return vs Industry: 5GH underperformed the German Healthcare industry which returned -2% over the past year.

Return vs Market: 5GH underperformed the German Market which returned 6.4% over the past year.

Price Volatility

Is 5GH's price volatile compared to industry and market?
5GH volatility
5GH Average Weekly Movement7.9%
Healthcare Industry Average Movement5.2%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 5GH's share price has been volatile over the past 3 months.

Volatility Over Time: 5GH's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20111,774Helmy Eltoukhyhttps://guardanthealth.com

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection.

Guardant Health, Inc. Fundamentals Summary

How do Guardant Health's earnings and revenue compare to its market cap?
5GH fundamental statistics
Market cap€1.94b
Earnings (TTM)-€442.34m
Revenue (TTM)€520.30m

3.7x

P/S Ratio

-4.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
5GH income statement (TTM)
RevenueUS$563.95m
Cost of RevenueUS$227.05m
Gross ProfitUS$336.90m
Other ExpensesUS$816.35m
Earnings-US$479.45m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-3.94
Gross Margin59.74%
Net Profit Margin-85.02%
Debt/Equity Ratio718.4%

How did 5GH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.